In a recent systematic review and meta-analysis, researchers compared the effects of SGLT-2 inhibitors, DPP-4 inhibitors, GLP-1 agonists, and other antidiabetic agents in improving left ventricular remodeling among patients with type 2...
In a recent systematic review and meta-analysis, researchers compared the effects of SGLT-2 inhibitors, DPP-4 inhibitors, GLP-1 agonists, and other antidiabetic agents in improving left ventricular remodeling among patients with type 2...
In a recent systematic review...